# ScoreItem: pH Urinário

**ID:** `c77cedd3-2800-7e89-bace-e71b69f73aaa`
**FullName:** pH Urinário (Exames - Laboratoriais)
**Unit:** unidade

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 7 artigos
- Avg Similarity: 0.574

---

## Contexto

Você é um especialista em medicina funcional integrativa e está contribuindo com o **Escore Plenya** — um escore completo de análise de saúde que avalia todos os aspectos da saúde, performance e longevidade humana. Cada ScoreItem representa um parâmetro clínico, laboratorial, genético, comportamental ou histórico que compõe esse escore.

Seu papel é gerar conteúdo clínico de alta qualidade para enriquecer cada parâmetro do escore com relevância clínica, orientação ao paciente e conduta prática.

**Regras inegociáveis:**
- Use **apenas** o conhecimento médico real consolidado e os dados presentes nos chunks científicos abaixo
- **Não alucine, não invente** dados, estudos, estatísticas ou referências que não estejam nos chunks ou no seu conhecimento médico estabelecido
- Se um dado específico não constar nos chunks e não for do seu conhecimento consolidado, **não o inclua**
- Seja preciso: prefira omitir a inventar

## Instrução

Com base nos chunks científicos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `c77cedd3-2800-7e89-bace-e71b69f73aaa`.**

```json
{
  "score_item_id": "c77cedd3-2800-7e89-bace-e71b69f73aaa",
  "clinical_relevance": "Texto técnico para médicos (1000-5000 chars): definição fisiológica precisa, valores de referência e interpretação, fisiopatologia resumida, dados epidemiológicos com números concretos, estratificação de risco baseada em evidências.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que é este parâmetro sem jargões, por que é importante para a saúde, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta clínica em Markdown (1000-5000 chars): investigação complementar necessária, critérios de encaminhamento a especialistas, intervenções baseadas em evidências. Use bullet points, seções e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto clínico: 1-9 pts
- Alto impacto clínico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Critérios: gravidade/mortalidade (40%), prevalência (30%), intervencionabilidade (30%)

---

### Contexto Científico

**ScoreItem:** pH Urinário (Exames - Laboratoriais)
**Unidade:** unidade

**30 chunks de 7 artigos (avg similarity: 0.574)**

### Chunk 1/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** discussion | **Similarity:** 0.631

pH of the urine was categorized as follows; 5, 6, 6.5, 7, 8 and 9.e Urisys 2400 and Cobas u 601 urine analyzers both contain a built-in refractometer, and the specic gravity (SG) was measured via refractometry. e scale of urine SG ranged from 1.000 to 1.050. In dilute urine, the RBCs absorb water, swell, and may rupture. In concentrated urine, the RBCs tend to shrink and become crenated. A urine SG of 1.010 corresponds to approximately 300mOsm/kg, similar to the osmolarity of  plasma22, and a urine SG > 1.020 oen indicates  dehydration23. In this study, therefore, urine samples with SG < 1.010 and > 1.020 were considered dilute and concentrated urine, respectively.Statistical analysis. e data are expressed as the median (interquartile range). e values obtained for the two groups were compared using the Mann–Whitney U test.

---

### Chunk 2/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.623

tNZJMed.1992;22:334–337.338.GilbertRE,AkdenizA,JerumsG.Detectionofmicroalbuminuriaindiabeticpatientsbyurinarydipstick.DiabetesResClinPract.1997;35:57–60.339.GrazianiMS,GambaroG,MantovaniL,etal.Diagnosticaccuracyofa
reagentstripforassessingurinaryalbuminexcretioninthegeneralpopulation.NephrolDialTransplant.2008;24:1490–1494.340.GuyM,NewallR,BorzomatoJ,etal.Useofarst-lineurineprotein-to-creatinineratiostriptestonrandomurinestoruleoutproteinuriain
patientswithchronickidneydisease.NephrolDialTransplant.2008;24:1189–1193.341.GuyM,NewallR,BorzomatoJ,etal.Diagnosticaccuracyoftheurinary
albumin:creatinineratiodeterminedbytheCLINITEKMicroalbuminandDCA2000þfortherule-outofalbuminuriainchronickidneydisease.ClinChimActa.2008;399:54–58.342.HasslacherC,MullerP,SchlipfenbacherRL.ResultsofamulticentrestudyforthedeterminationofmicroalbuminuriawithMicral-Test.KlinischesLabor.1995;41:441–447.343.HodelNC,HamadA,ReitherK,etal.Comparisonoftwodifferent
semiquantitativeurinarydipsticktestswithal

---

### Chunk 3/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.606

g.ClinNephrol.1999;51:220–227.366.ParsonsMP,NewmanDJ,NewallRG,etal.Validationofapoint-of-care
assayfortheurinaryalbumin:creatinineratio.ClinChem.1999;45:414–417.367.PendersJ,FiersT,DelangheJR.Quantitativeevaluationofurinalysistest
strips.ClinChem.2002;48:2236–2241.368.PoulsenPL,MogensenCE.Clinicalevaluationofatestforimmediateand
quantitativedeterminationofurinaryalbumin-to-creatinineratio.Abrief
report.DiabetesCare.1998;21:97–98.369.PugiaMJ,LottJA,KajimaJ,etal.Screeningschoolchildrenfor
albuminuria,proteinuriaandoccultbloodwithdipsticks.ClinChemLabMed.1999;37:149–157.370.SakaiN,FuchigamiH,IshizukaT,etal.Relationshipbetweena
urineprotein-to-creatinineratioof150mg/gramcreatinineanddipstickgradeinthehealthcheckup:substantialnumberoffalse-
negativeresultsforchronickidneydisease.TokaiJExpClinMed.2019;44:118–123.371.SalinasM,López-GarrigósM,FloresE,etal.Urinaryalbuminstripassay
asascreeningtesttoreplacequantitativetechnologyincertain
conditions.ClinChemLabMed.2018;57:204–209.

---

### Chunk 4/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** other | **Similarity:** 0.597

ects the morphology of RBCs. In highly alkaline urine (pH > 9), RBCs may undergo lysis due to swelling of the outer membrane  layers24. In the data obtained via the UF-1000i urine analyzer, the pH of urine from bladder cancer and glomerular disease was 6 (56.5) and 5 (56.5) (p < 0.001), respectively. ere were 7/5271 (0.13%) urine specimens with pH ≥ 9 among the patients with bladder cancer and 2/3892 (0.05%) among the patients with glomerular disease. In the data obtained via the Cobas 6500 urine analyzer, the pH of urine from bladder cancer and glomerular disease was 6 (57) and 5 (56) (p < 0.001), respectively. ere were 16/7239 (0.22%) urine specimens with pH ≥ 9 among the patients with bladder cancer and 6/3782 (0.16%) among the patients with glomerular disease.Correlation between the urinary dipstick blood test and urinary RBC counts.

---

### Chunk 5/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** results | **Similarity:** 0.596

and digital imaging in one system: A multicenter performance evaluation of the cobas 6500 urine work area. Pract. Lab. Med. 17, e00139 (2019). 30. aller, T. R. & Wang, L. P. Evaluation of asymptomatic microscopic hematuria in adults. Am. Fam. Phys. 60, 11431152 (1999). 31. Palsson, R., Srivastava, A. & Waikar, S. S. Performance of the automated urinalysis in diagnosis of proliferative glomerulonephritis. Kidney Int. Rep. 4, 723727 (2019). 32. Orlandi, P. F. et al. Hematuria as a risk factor for progression of chronic kidney disease and death: Findings from the chronic renal insuciency cohort (CRIC) study. BMC Nephrol. 19, 150 (2018). 33. Schulman, G. et al. Risk factors for progression of chronic kidney disease in the EPPIC trials and the eect of AST-120. Clin. Exp. Nephrol. 22, 299308 (2018). 34. Mashitani, T. et al.

---

### Chunk 6/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** results | **Similarity:** 0.595

100 RBCs/HPF).e presence of blood and the pH of the urine were measured via a dipstick test. e urine color and the dipstick test results were read via an automatic reader. e Urisys 2400 automated urine test strip analyzer (Roche Diagnostics GmbH) was used to read the dipstick tests of the urine specimens examined using the UF-1000i urine analyzer, whereas the Cobas 6500 urine analyzer was used to conduct the urine dipstick test as well as the urine RBC counting using two modules, the Cobas u 601 for the urine dipstick and the Cobas u 701 for urine microscopy. Test strips in the Urisys 2400 cassettes and the cobas u packs were used with the Urisys 2400 analyzer and the Cobas u 601 analyzer, respectively. In both analyzers, dipstick hematuria was graded as −, ±, 1+, 2+, 3+, and 4+.

---

### Chunk 7/30
**Article:** Proteinuria (2023)
**Journal:** StatPearls Publishing
**Section:** abstract | **Similarity:** 0.582

Comprehensive clinical review of proteinuria covering definition, etiology, diagnosis, and management. Proteinuria serves as a marker of kidney damage assisting with diagnosis, prognosis, and therapy. Normal protein excretion is <150 mg/24 hours. Severity categories: nephritic range (150-3,500 mg/24h) and nephrotic range (>3,500 mg/24h). Urine dipstick provides semi-quantitative screening but has important limitations: false-positives with dehydration, alkaline urine, UTI; inability to detect positively charged proteins. UK CKD guidelines define significant proteinuria as UPCR >45 mg/mmol. Quantitative methods (spot UPCR preferred for convenience and reliability, or 24-hour urine collection for accuracy) are indicated when dipstick is positive or proteinuria >1 g/day is suspected. Early detection and quantification are crucial given associations with progressive renal disease and cardiovascular complications.

---

### Chunk 8/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.581

 52.361.OlivariusND,MogensenCE.Danishgeneralpractitioners’estimationofurinaryalbuminconcentrationinthedetectionofproteinuriaand
microalbuminuria.BrJGenPract.1995;45:71–73.362.OstaV,NatoliV,DiéguezS.[Evaluationoftworapidtestsforthe
determinationofmicroalbuminuriaandtheurinaryalbumin/creatinine
ratio].AnPediatr(Barc).2003;59:131–137[inSpanish].363.OyaertM,DelangheJR.Semiquantitative,fullyautomatedurineteststrip
analysis.JClinLabAnal.2019;33:e22870.364.ParkerJL,KirmizS,NoyesSL,etal.Reliabilityofurinalysisfor
identicationofproteinuriaisreducedinthepresenceofotherabnormalitiesincludinghighspecicgravityandhematuria.UrolOncol.2020;38:853.e859–853.e915.365.ParsonsM,NewmanDJ,PugiaM,etal.Performanceofareagentstrip
deviceforquantitationoftheurinealbumin:creatinineratioinapoint
ofcaresetting.ClinNephrol.1999;51:220–227.366.ParsonsMP,NewmanDJ,NewallRG,etal.Validationofapoint-of-care
assayfortheurinaryalbumin:creatinineratio.ClinChem.1999;45:414–417.367.PendersJ,FiersT,DelangheJR.Quan

---

### Chunk 9/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.580

inJapan.OpenForumInfectDis.2018;5:ofy216.381.YangCJ,ChenDP,WenYH,etal.Evaluationthediagnosticaccuracyof
albuminuriadetectioninsemi-quantitativeurinalysis.ClinChimActa.2020;510:177–180.382.KouriT,NokelainenP,PelkonenV,etal.EvaluationoftheARKRAYAUTIONElevenreectometerindetectingmicroalbuminuriawithAUTIONScreenteststripsandproteinuriawithAUTIONSticks10PAstrips.ScandJClinLabInvest.2008;69:52–64.383.NagrebetskyA,JinJ,StevensR,etal.Diagnosticaccuracyofurinedipsticktestinginscreeningformicroalbuminuriaintype2diabetes:acohortstudyinprimarycare.FamPract.2012;30:142–152.384.NahEH,ChoS,KimS,etal.Comparisonofurinealbumin-to-creatinineratio(ACR)betweenACRstriptestandquantitativetestinprediabetesanddiabetes.AnnLabMed.2016;37:28–33.385.ShinJI,ChangAR,GramsME,etal.Albuminuriatestinginhypertensionanddiabetes:anindividual-participantdatameta-analysisinaGlobalConsortium.Hypertension.2021;78:1042–1052.386.PantaloneKM,JiX,KongSX,etal.Unmetneedsandopportunitiesforoptimalmanagementofpatientswithty

---

### Chunk 10/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** other | **Similarity:** 0.579

hy: A cohort study. Am. J. Kidney Dis. 76, 9099 (2020). 21. Wu, Y. et al. e association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: A biopsy-based study. J. Endocrinol. Investig. 43, 12131220 (2020). 22. Imran, S., Eva, G., Christopher, S., Flynn, E. & Henner, D. Is specic gravity a good estimate of urine osmolality? J. Clin. Lab. Anal. 24, 426430 (2010). 23. Sawka, M. N. et al. American College of Sports Medicine position stand. Exercise and uid replacement. Med. Sci. Sports Exerc. 39, 377390 (2007). 24. Sharp, V. J., Barnes, K. T. & Erickson, B. A. Assessment of asymptomatic microscopic hematuria in adults. Am. Fam. Phys. 88, 747754 (2013). 25. Grossfeld, G. D. et al. Evaluation of asymptomatic microscopic hematuria in adults: e American Urological Association best practice policyPart I: Denition, detection, prevalence, and etiology. Urology 57, 599603 (2001). 26. Yuste, C. et al.

---

### Chunk 11/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.579

hohavemetabolicdisordersandareonaverylow–proteindiet,acystatinC–basedequationislikelymoreappropriate.1.3EvaluationofalbuminuriaAlbuminuriareferstoabnormallossofalbuminintheurine(urineACR$30mg/gor$3mg/mmol).Albuminisonetypeofplasmaproteinfoundintheurineinnormalsubjectsand
inlargerquantityinpeoplewithkidneydisease.IntheKDIGO
2012ClinicalPracticeGuidelinefortheEvaluationand
ManagementofChronicKidneyDisease,1clinicalterminologywaschangedtofocusonalbuminuriaratherthanproteinuria
asalbuministheprincipalcomponentofurinaryproteininmostkidneydiseases.Epidemiologicdatademonstrateastrongrelationshipbetweenthequantityofurinealbuminwithboth
kidneyandCVDriskandobservedCVDevenatverylow
levels,andassaystomeasurealbuminaremorepreciseand
sensitivethanassaystomeasureurineprotein.Wereferto
albuminuriaorurinealbuminwhendiscussinggeneral
conceptsandwillrefereithertototalprotein,albumin,orother
specicproteinswhendiscussingthatparameterspecically.1.3.1GuidanceforphysiciansandotherhealthcareprovidersPrac

---

### Chunk 12/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.573

ta-analysis.ClinJAmSocNephrol.2022;17:1305–1315.193.vanEeghenSA,WiepjesCM,T’SjoenG,etal.CystatinC-basedeGFRchangesduringgender-afrminghormonetherapyintransgenderindividuals.ClinJAmSocNephrol.2023;18:1545–1554.194.PierreC,MarzinkeM,AhmedSB,etal.AACC/NKFguidancedocumenton
improvingequityinchronickidneydiseasecare.JApplLabMed.2023;8:789–816.195.NgDK,FurthSL,WaradyBA,etal.Self-reportedrace,serumcreatinine,
cystatinC,andGFRinchildrenandyoungadultswithpediatrickidney
referenceswww.kidney-international.orgS298KidneyInternational(2024)105(Suppl4S),S117–S314

diseases:areportfromtheChronicKidneyDiseaseinChildren(CKiD)study.AmJKidneyDis.2022;80:174–185.e1.196.Luna-ZaizarH,Virgen-MontelongoM,Cortez-AlvarezCR,etal.Invitro
interferencebyacetaminophen,aspirin,andmetamizoleinserum
measurementsofglucose,urea,andcreatinine.ClinBiochem.2015;48:538–541.197.GreenbergN,RobertsWL,BachmannLM,etal.Specicitycharacteristicsof7commercialcreatininemeasurementproceduresbyenzymaticand
Jaffemethodpri

---

### Chunk 13/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.572

9,540Thecausalityofsuchassociationsremainstobedemonstrated.Denitionandprevalence.SerumbicarbonateconcentrationbeginstofallprogressivelyonceeGFRfallsbelow60ml/minper1.73m2withreductionsmostevidentinCKDstagesG4–G5(Figure28,541Table23).Theadjustedadultprevalenceofserumbicarbonate<22mmol/lwas7.7%and6.7%inthosewithandwithoutdiabetesatstageG3,A1,respectively,increasingto38.3%and35.9%byCKDstageG5,A3.PracticePoint3.10.1:InpeoplewithCKD,consideruseofpharmacologicaltreatmentwithorwithoutdietaryinter-
ventiontopreventdevelopmentofacidosiswithpotential
clinicalimplications(e.g.,serumbicarbonate<18mmol/linadults).PracticePoint3.10.2:Monitortreatmentformetabolicacidosistoensureitdoesnotresultinserumbicarbonate
concentrationsexceedingtheupperlimitofnormaland
doesnotadverselyaffectBPcontrol,serumpotassium,or
uidstatus.TheWorkGrouphasnotprovidedagradedrecommen-dationforthetreatmentofacidosisduetoalackoflarge-scale
RCTssupportingitsuse.In2012,a2Brecommendationwasjustiedbecausealkalisupplementationm

---

### Chunk 14/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.572

S,CarlinJB,etal.Albuminuria:populationepidemiology
andconcordanceinAustralianchildrenaged11–12yearsandtheirparents.BMJOpen.2019;9:75–84.308.RademacherER,SinaikoAR.Albuminuriainchildren.CurrOpinNephrolHypertens.2009;18:246–251.309.TsiousC,MazarakiA,DimitriadisK,etal.Microalbuminuriainthepaediatricage:currentknowledgeandemergingquestions.ActaPaediatr.2011;100:1180–1184.310.EmmaF,GoldsteinS,BaggaA,etal.PediatricNephrology.8thed.Springer;2022.311.BrinkmanJW,deZeeuwD,DukerJJ,etal.Falselylowurinaryalbuminconcentrationsafterprolongedfrozenstorageofurinesamples.ClinChem.2005;51:2181–2183.312.SacksDB,ArnoldM,BakrisGL,etal.Executivesummary:guidelinesand
recommendationsforlaboratoryanalysisinthediagnosisandmanagementofdiabetesmellitus.ClinChem.2011;57:793–798.313.SeegmillerJC,MillerWG,BachmannLM.Movingtowardstandardizationofurinealbuminmeasurements.EJIFCC.2017;28:258–267.314.NationalInstituteofStandardsandTechnology.CerticationofStandardReferenceMaterial2925RecombinantHumanSerumA

---

### Chunk 15/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.568

1–A3).Theyaxisrepresentsthemeta-analyzedabsolutedifferencefromthemeanadjustedvalueataneGFRof80ml/minper1.73m2andalbuminexcretion<30mg/g(<3mg/mmol).ReproducedfromAmericanJournalofKidneyDiseases,volume73,issue2,InkerLA,GramsME,LeveyAS,etal.RelationshipofestimatedGFRand
albuminuriatoconcurrentlaboratoryabnormalities:anindividual
participantdatameta-analysisinaGlobalConsortium,pages206–217,Copyrightª2018,withpermissionfromtheNationalKidneyFoundation,Inc.541
Table23|Variationoflaboratoryvaluesinalargepopulationdatabaseabyagegroup,sex,andeGFR;bicarbonate,mmol/l,mean(SD),andn[3,990,898Measure,mean(SD)Age(yr)SexGFRcategory(ml/minper1.73m2)105D90–10475–8960–7445–5930–4415–290–14Serumbicarbonate$65Female27.4(4.1)27.1(2.9)26.9(2.9)26.8(2.9)26.5(3.1)25.9(3.5)24.8(4.0)24.0(4.8)Male27.1(3.9)26.6(2.9)26.7(2.9)26.5(2.9)26.1(3.1)25.3(3.8)24.1(4.0)24.2(4.8)<65Female25.2(2.8)26.1(2.8)26.3(2.8)26.4(2.9)26.2(3.2)25.1(3.6)23.6(4.2)24.0(5.0)Male26.4(2.8)26.5(3.0)26.6(2.7)26.5(2.9)25.9(3.2)

---

### Chunk 16/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.566

etablesorsodiumbicarbonate.ClinJAmSocNephrol.2013;8:371–381.550.GorayaN,SimoniJ,JoCH,etal.Treatmentofmetabolicacidosisin
patientswithstage3chronickidneydiseasewithfruitsand
vegetablesororalbicarbonatereducesurineangiotensinogenand
preservesglomerularltrationrate.KidneyInt.2014;86:1031–1038.551.NoceA,MarroneG,WilsonJonesG,etal.Nutritionalapproachesforthe
managementofmetabolicacidosisinchronickidneydisease.Nutrients.2021;13:2534.552.BrownDD,RoemJ,NgDK,etal.LowserumbicarbonateandCKD
progressioninchildren.ClinJAmSocNephrol.2020;15:755–765.553.BrownDD,CarrollM,NgDK,etal.Longitudinalassociationsbetween
lowserumbicarbonateandlineargrowthinchildrenwithCKD.

---

### Chunk 17/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.565

99–203.351.LimS,YuHJ,LeeS,etal.EvaluationoftheURiSCAN2ACRStripto
estimatetheurinealbumin/creatinineratios.JClinLabAnal.2017;32:e22289.352.LinCJ,ChenHH,PanCF,etal.Thecharacteristicsofnewsemi-
quantitativemethodfordiagnosingproteinuriabyusingrandomurine
samples.JClinLabAnal.2011;25:14–19.353.LloydMM,KuylJ,vanJaarsveldH.Evaluationofpoint-of-caretestsfor
detectingmicroalbuminuriaindiabeticpatients.SAfrFamPract.2011;53:281–286.354.MarshallSM,ShearingPA,AlbertiKG.Micral-teststripsevaluatedfor
screeningforalbuminuria.ClinChem.1992;38:588–591.355.MasimangoMI,HermansMP,MalembakaEB,etal.Impactofruralversus
urbansettingonkidneymarkers:across-sectionalstudyinSouth-Kivu,
DRCongo.BMCNephrol.2021;22:234.356.MasimangoMI,SumailiEK,JadoulM,etal.Prevalenceof
microalbuminuriaanddiagnosticvalueofdipstickproteinuriain
outpatientsfromHIVclinicsinBukavu,theDemocraticRepublicof
Congo.BMCNephrol.2014;15:146.357.McTaggartMP,PriceCP,PinnockRG,etal.Thediagnosticaccuracyofa
urinealbumin-creatinineratiopoint

---

### Chunk 18/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.564

albumindeterminationinpatientswithtype1diabetes.BrazJMedBiolRes.2002;35:337–343.347.KimY,ParkS,KimMH,etal.Canasemi-quantitativemethodreplacethe
currentquantitativemethodfortheannualscreeningofmicroalbuminuriainpatientswithdiabetes?Diagnosticaccuracyandcost-savinganalysisconsideringthepotentialhealthburden.PLoSOne.2020;15:e0227694.348.LeFlochJP,MarreM,RodierM,etal.InterestofClinitekMicroalbumininscreeningformicroalbuminuria:resultsofamulticentrestudyin302diabeticpatients.DiabetesMetab.2001;27:36–39.349.LeongSO,LuiKF,NgWY,etal.Theuseofsemi-quantitativeurinetest-
strip(MicralTest)formicroalbuminuriascreeninginpatientswithdiabetesmellitus.SingaporeMedJ.1998;39:101–103.350.LimD,LeeDY,ChoSH,etal.Diagnosticaccuracyofurinedipstickforproteinuriainolderoutpatients.KidneyResClinPract.2014;33:199–203.351.LimS,YuHJ,LeeS,etal.EvaluationoftheURiSCAN2ACRStripto
estimatetheurinealbumin/creatinineratios.JClinLabAnal.2017;32:e22289.352.LinCJ,ChenHH,PanCF,etal.Thecharacteristicsofnewsemi-
quantit

---

### Chunk 19/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** other | **Similarity:** 0.564

according to the SG. In most cases, the RBC counts were graded signicantly lower in urine specimens with SG < 1.010 than in those with SG 1.0101.020. High urine SG (> 1.020) did not seem to alter the RBC counting via the UF-1000i urine 
Figure1.  Specic gravities (SG) of urine specimens measured using the UF-1000i urine analyzer ((A) bladder cancer; (B) glomerular disease) and the Cobas 6500 urine analyzer ((C) bladder cancer; (D) glomerular disease).

4
Scientific Reports |        (2021) 11:20981  | https://doi.org/10.1038/s41598-021-00457-6
analyzer, but tended to decrease the RBC counts in patients with glomerular disease when the urinalyses were performed using the Cobas 6500 urine analyzer (Supplementary TablesS1S4, Supplementary Figs.S1S4).Urine pH is another factor that aects the morphology of RBCs. In highly alkaline urine (pH > 9), RBCs may undergo lysis due to swelling of the outer membrane  layers24.

---

### Chunk 20/30
**Article:** Outpatient crystalluria: prevalence, crystal types, and associations with comorbidities and urinary tract infections at a provincial hospital (2025)
**Journal:** Iranian Journal of Microbiology
**Section:** abstract | **Similarity:** 0.563

Background and Objectives: Crystalluria refers to the occurrence of crystals in urine resulting from urinary supersaturation, which disrupts the balance between factors that promote and those that inhibit crystal formation in urine. This study examined crystalluria occurrence in 1,025 urine samples from outpatients at a provincial hospital. Results: 22.04% of samples showed crystalluria with mean patient age of 51.3 years. The most common crystal types were calcium oxalate (46.4%), uric acid (23.5%), urates (15.1%) and struvite (9.3%). Diabetes, kidney failure, prostatitis, and nephrotic syndrome were associated with crystal formation. The prevalence of urinary tract infections in patients with urinary crystals was 10.6%. Notably, struvite crystals correlated with bacterial infections. Conclusion: Monitoring crystals is vital for preventing kidney stone development and infection-related complications in susceptible populations.

---

### Chunk 21/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.560

eyDiseases,volume73,issue2,InkerLA,GramsME,LeveyAS,etal.RelationshipofestimatedGFRandalbuminuriatoconcurrentlaboratoryabnormalities:anindividualparticipantdatameta-
analysisinaGlobalConsortium,pages206–217,Copyrightª2018,withpermissionfromtheNationalKidneyFoundation,Inc.541
chapter3www.kidney-international.orgS230KidneyInternational(2024)105(Suppl4S),S117–S314

withaneGFRof<60ml/minper1.73m2atbaseline(amongwhom71primaryoutcomesaccrued)werecomparedwiththe5181peoplewithaneGFRof$60ml/minper1.73m2(568outcomes).611Certaintyofevidence.Theoverallcertaintyoftheevidenceforuricacid–loweringtherapyamongpeoplewithCKDandhyperuricemiaisverylow(seeSupplementaryTableS11150,612–614).ThecriticaloutcomeofdelayingprogressionofCKDwasaddressedby7RCTs.150,612,615–619The2largestRCTswereconsideredtohavealowriskofbias.615,616Thecertaintyoftheevidencewasdowngradedforinconsistency
becausetherewassubstantialstatisticalheterogeneitydetectedinthemeta-analysis(I2¼50%)andtheestimatedRRsrangedfrom0.05to2.96

---

### Chunk 22/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.560

22:369.318.McTaggartMP,NewallRG,HirstJA,etal.Diagnosticaccuracyofpoint-of-
caretestsfordetectingalbuminuria:asystematicreviewandmeta-analysis.AnnInternMed.2014;160:550–557.319.AbitbolC,ZillerueloG,FreundlichM,etal.Quantitationofproteinuriawithurinaryprotein/creatinineratiosandrandomtestingwithdipsticksinnephroticchildren.JPediatr.1990;116:243–247.320.AgardhCD.Anewsemiquantitativerapidtestforscreeningformicroalbuminuria.PracticalDiabetes.1993;10:146–147.321.AgarwalR,PanesarA,LewisRR.Dipstickproteinuria:canitguide
hypertensionmanagement?AmJKidneyDis.2002;39:1190–1195.322.AroraS,LongT,MenchineM.Testcharacteristicsofurinedipstickfor
identifyingrenalinsufciencyinpatientswithdiabetes.WestJEmergMed.2011;12:250–253.323.ChangCC,SuMJ,HoJL,etal.Theefcacyofsemi-quantitativeurineprotein-to-creatinine(P/C)ratioforthedetectionofsignicantproteinuriainurinespecimensinhealthscreeningsettings.Springerplus.2016;5:1791.324.ChoMC,JiM,KimSY,etal.EvaluationoftheURiSCANsupercassetteACRsemiquantita

---

### Chunk 23/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** methods | **Similarity:** 0.559

tudy was approved by the Institutional Review Board (IRB) of Asan Medical Center (IRB No. S2021-0242-0001); the requirement of obtaining informed consent was waived owing to the retrospective study design. All methods were performed in accordance with the Declaration of Helsinki.Laboratory parameters. Urine specimens were randomly obtained at the outpatient clinic and trans-ported to the clinical laboratory without preservatives. e laboratory aimed to report the urinalysis results within 1h of sampling.Urinary RBCs counted via either the UF-1000i urine analyzer or the Cobas 6500 urine analyzer were reported as follows: grade 1 (02 RBCs/HPF), grade 2 (35 RBCs/HPF), grade 3 (610 RBCs/HPF), grade 4 (1120 RBCs/HPF), grade 5 (2130 RBCs/HPF), grade 6 (31100 RBCs/HPF) and grade 7 (> 100 RBCs/HPF).e presence of blood and the pH of the urine were measured via a dipstick test. e urine color and the dipstick test results were read via an automatic reader.

---

### Chunk 24/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.559

rshallSM,AlbertiKG.Screeningforearlydiabeticnephropathy.AnnClinBiochem.1986;23(Pt2):195–197.290.MillerWG,BrunsDE,HortinGL,etal.Currentissuesinmeasurementandreportingofurinaryalbuminexcretion.ClinChem.2009;55:24–38.291.ChitaliaVC,KothariJ,WellsEJ,etal.Cost-benetanalysisandpredictionof24-hourproteinuriafromthespoturineprotein-creatinineratio.ClinNephrol.2001;55:436–447.292.CoteAM,BrownMA,LamE,etal.Diagnosticaccuracyofurinaryspotprotein:creatinineratioforproteinuriainhypertensivepregnant
women:systematicreview.BMJ.2008;336:1003–1006.293.DysonEH,WillEJ,DavisonAM,etal.Useoftheurinaryproteincreatinine
indextoassessproteinuriainrenaltransplantpatients.NephrolDialTransplant.1992;7:450–452.294.Leanos-MirandaA,Marquez-AcostaJ,Romero-ArauzF,etal.Protein:
creatinineratioinrandomurinesamplesisareliablemarkerof
increased24-hourproteinexcretioninhospitalizedwomenwith
hypertensivedisordersofpregnancy.ClinChem.2007;53:1623–1628.295.LemannJJr,DoumasBT.Proteinuriainhealthanddiseaseassessedby

---

### Chunk 25/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.558

chmannLM.Movingtowardstandardizationofurinealbuminmeasurements.EJIFCC.2017;28:258–267.314.NationalInstituteofStandardsandTechnology.CerticationofStandardReferenceMaterial2925RecombinantHumanSerumAlbuminSolution(PrimaryReferenceCalibratorforUrineAlbumin)(Frozen).U.S.DepartmentofCommerce,NIST;2020.315.CarterJL,ParkerCT,StevensPE,etal.Biologicalvariationofplasmaand
urinarymarkersofacutekidneyinjuryinpatientswithchronickidneydisease.ClinChem.2016;62:876–883.316.NationalInstituteforHealthandCareExcellence.Point-of-carecreatininedevicestoassesskidneyfunctionbeforeCTimagingwithintravenous
contrast.NICEGuideline[NG37].NICE;2019.317.BatteA,MurphyKJ,NamazziR,etal.Evaluatingkidneyfunctionusingapoint-of-carecreatininetestinUgandanchildrenwithseveremalaria:aprospectivecohortstudy.BMCNephrol.2021;22:369.318.McTaggartMP,NewallRG,HirstJA,etal.Diagnosticaccuracyofpoint-of-
caretestsfordetectingalbuminuria:asystematicreviewandmeta-analysis.AnnInternMed.2014;160:550–557.319.AbitbolC,ZillerueloG,F

---

### Chunk 26/30
**Article:** Fisiologia e Bioquímica do Sistema Imune II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.558

nsulina ideal ~6–7 (até 8 em inflamação).
- Homocisteína: <7,9; correlaciona com PCR; polimorfismos FUT/MTHFR podem elevá-la.
- PCR: desejável <1; risco médio 1–3; alto >3; casos extremos >1.000 em crise; usar PCR-us para sensibilidade; VHS para trajetória da inflamação.
### 12. Preferências e filosofia de ciclo
- Estratégias cíclicas (jejum, low carb, cetogênica limpa, exercício em jejum) para treinar flexibilidade metabólica e melhorar uso de corpos cetônicos.
- Protocolos fundamentados em literatura (PubMed: “Inflammation and Phytochemicals/Bioactive Compounds”) e prática clínica, com resultados consistentes.
### 13. Observações Motivacionais e Agradecimentos
- Inspiração: “A constância dos bons resultados que conduz os homens à felicidade.”
- Agradecimentos e convite à prática contínua; compromisso de apoio.
## ❓ Perguntas
- [Inserir Pergunta/Confusão]
## 📚 Tarefas
- [ ] 1.

---

### Chunk 27/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.558

FactorFalselyelevatedACRorPCRFalsedecreaseinACRorPCRVariabilityinurinealbuminorproteinHematuriaIncreasesalbuminandproteinintheurineMenstruationIncreasesalbuminandproteinintheurineExercise259IncreasesalbuminandproteinintheurineInfection260,261SymptomaticurinaryinfectioncancauseproductionofproteinfromtheorganismNonalbuminproteinsOtherproteinsmaybemissedbyalbuminreagentstripsVariabilityinurinarycreatinineconcentrationBiologicalsexFemaleshavelowerurinarycreatinineexcretion,thereforehigherACRandPCRMaleshavehigherurinarycreatinineexcretion,thereforelowerACRandPCRWeight73,160LowurinarycreatinineexcretionconsistentwithlowweightcancausehighACRorPCRrelativetotimedexcretionHighurinarycreatinineexcretionconsistentwithhighweightcancauselowACRorPCRrelativetotimedexcretionChangesincreatinineexcretionLowerurinarycreatinineexcretionwithAKIorlow-proteinintakeHighurinarycreatinineexcretionwithhigh-proteinintakeorexerciseACR,albumin-to-creatinineratio;AKI,acutekidneyinjury;PCR,protein-to-creatinineratio.

---

### Chunk 28/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** other | **Similarity:** 0.556

omparison of automated urinalysis systems and manual microscopy. Clin. Chim. Acta 384, 2834 (2007). 6. Cavanaugh, C. & Perazella, M. A. Urine sediment examination in the diagnosis and management of kidney disease: Core cur-riculum 2019. Am. J. Kidney Dis. 73, 258272 (2019). 7. Becker, G. J., Garigali, G. & Fogazzi, G. B. Advances in urine microscopy. Am. J. Kidney Dis. 67, 954964 (2016). 8. Oyaert, M. & Delanghe, J. Progress in automated urinalysis. Ann. Lab. Med. 39, 1522 (2019). 9. Lee, W., Ha, J. S. & Ryoo, N. H. Comparison of the automated cobas u 701 urine microscopy and UF-1000i ow cytometry systems and manual microscopy in the examination of urine sediments. J. Clin. Lab. Anal. 30, 663671 (2016). 10. Moreno, J. A. et al. Glomerular hematuria: Cause or consequence of renal inammation? Int. J. Mol. Sci. 20, 2205 (2019). 11. Kincaid-Smith, P. & Fairley, K. e investigation of hematuria. Semin. Nephrol. 25, 127135 (2005). 12.

---

### Chunk 29/30
**Article:** Bioquímica Metabólica nos Exercícios - Parte III (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.556

exercício e recuperação; manter R basal 0,98–1,02 e prevenir acidose crônica e sequestro ósseo.
- [ ] 18. Programar reavaliação de exames e desempenho em 1–2 meses, até 2025-12-20 ou 2026-01-20; ajustar o plano conforme resultados.
- [ ] 19. Educar pacientes sobre metas bioquímicas, uso correto de aeróbico em jejum e reavaliações frequentes, reforçando adesão por metas claras e feedback imediato.

---

## Teaching Note

Data e Hora: 2025-11-20 19:22:20
Local: [Inserir Local]
Aula: Medicina Funcional Integrativa - Bioquímica do Metabolismo nas Atividades Físicas
## Visão Geral
A aula abordou a bioquímica do metabolismo em atividades físicas, focando em como a intensidade do exercício influencia as respostas hormonais e metabólicas.

---

### Chunk 30/30
**Article:** Pathophysiology and Main Molecular Mechanisms of Urinary Stone Formation and Recurrence (2024)
**Journal:** International Journal of Molecular Sciences
**Section:** abstract | **Similarity:** 0.555

Urinary stone disease (nephrolithiasis) is a multifactorial condition affecting 12% of the global population with recurrence rates as high as 50% within 5 years after first stone onset. This comprehensive review examines the pathophysiology and molecular mechanisms underlying urinary stone formation and recurrence. The review covers crystal nucleation, aggregation, and retention processes, highlighting the role of urinary supersaturation, pH imbalances, and inhibitor deficiencies. Special attention is given to calcium oxalate and calcium phosphate stones (80% of cases), uric acid stones, cystine stones, and infection-related struvite crystals. Understanding these mechanisms is essential for developing targeted prevention and treatment strategies for this highly recurrent condition.

---

